Express Pharma

US FDA approves expanded use of Bristol Myers cancer drug Opdivo

The approval was based on data from a late-stage study showing the drug along with chemotherapy improved event-free survival and pathologic complete response compared to chemotherapy alone in patients with resectable non-small cell lung cancer

0 263